The latest research

30 April 2021
Spring 2021

Here we summarise three research papers from a recent issue of Optometry in Practice.

Retinal gene therapy: medicine of the near future

Jasleen K Jolly MCOptom

This review aims to provide clinicians with a basic understanding of genetics and gene therapy for managing ocular pathology.

Until relatively recently, gene therapy was something seen only in science fiction. Over the past 15 years, considerable progress has been made in the field, culminating in the arrival of a therapy to treat a rare inherited retinal disease, which has been approved by NICE for use as a treatment. Patients will now be seeking guidance about these treatments from their optometrist. This article will help with answering patient queries, managing patients and referring appropriately.

Read this paper: Retinal gene therapy: medicine of the near future

Sign in to continue

Forgotten password?

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

The College of Optometrists has issued a statement in response to news reports that many soft contact lenses in the US contain compounds called fluoropolymers, which are also known as per- and polyfluoroalkyl substances (PFAS).

As society continues to open up, the Optometry in Practice editorial board thought it opportune to reflect on the experiences of the pandemic to date and assess the impact on both eyecare professionals and our patients.

Have your paper included in a special issue of OPO, the College's leading international research journal.